HUMAN ISLET RESEARCH NETWORK MISSION
To better understand how human beta cells are lost in Type 1 Diabetes and to find innovative strategies to protect or replace functional beta cell mass in diabetic patients.
Our Research
Supporting Collaborative Research since 2014
The Human Islet Research Network (HIRN) was established in 2014 to help organize and support collaborative research related to the loss of functional beta cell mass in Type 1 Diabetes (T1D). The project consists of five independent research initiatives.
Research Resources
Latest News
HIRN Webinar Invitation: “Bifunctional Small Molecules: From PROTACs to Molecular Glues”
Tuesday, May 2, 2023 (12:00 pm Eastern / 9:00 am Pacific) Topics to be discussed: – Describe the different types of bifunctional molecules in drug discovery and development – Discuss…
Read MoreWebinar: “Stem Cell-based Platforms to Model Human Autoimmune Diabetes”
Click HERE to access the YouTube video of the recording. Tuesday, March 28, 2023 (1:00 PM Eastern | 10:00 AM Pacific) Presentations by: – Audrey Parent, PhD, University of California, San…
Read More
HIRN Funding Opportunity: Pancreas Knowledgebase Program (PanKbase)
(RFA-DK-22-018)
This Funding Opportunity Announcement (FOA) invites applications to develop a centralized resource of the human pancreas for diabetes research that will provide access to deeply curated high-quality datasets, knowledge in…
Read MoreConsortia
Independent Research Initiatives
HIRN-OPP
Opportunity Pool Projects
The Human Islet Research Network (HIRN) was established In 2014 to help organize and support collaborative research related to the loss of functional beta cell mass in Type 1 Diabetes (T1D). The project consists of five independent research initiatives.
